ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 12, December 2025 | pp. 978–984
DOI: 10.46882/AJIDR/148903
Article Type: Research Article
Title: Molecular epidemiology and antifungal susceptibility of Talaromyces marneffei in HIV-infected adults with systemic mycosis
Names of Authors: Sipho Mokoena¹*, Lukas Weber², Mei-Ling Chen³
Authors’ Affiliations: ¹Department of Internal Medicine, University of the Witwatersrand, Johannesburg, South Africa. ²Institute of Medical Mycology, University of Zurich, Zurich, Switzerland. ³Department of Infectious Diseases, National Taiwan University, Taipei, Taiwan.
Abstract: Dimorphic fungal infections represent major neglected causes of opportunistic mortality among travelers and immunocompromised patients with advanced HIV disease. We characterized the diagnostic yield of blood culture, antigen detection, and antifungal susceptibility among febrile HIV-positive patients presenting with hepatosplenomegaly and umbilicated skin papules. Clinical specimens from 185 patients with CD4 counts below 100 cells per microliter were evaluated via fungal culture and Mp1p antigen enzyme immunoassay. Systemic dimorphic mycosis was confirmed in 11.9 percent of cases, responding favorably to liposomal amphotericin B induction followed by oral itraconazole maintenance.
Keywords: Systemic mycosis, Opportunistic fungal infection, HIV/AIDS, Antifungal susceptibility, Medical mycology
Citation: Mokoena S, Weber L, Chen M (2025). Molecular epidemiology and antifungal susceptibility of Talaromyces marneffei in HIV-infected adults with systemic mycosis. African Journal of Infectious Diseases Research, 12(12): 978–984. DOI: 10.46882/AJIDR/148903
Manuscript Timeline: Received: October 20, 2025; Revised: November 21, 2025; Accepted: December 03, 2025; Published: December 09, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read